GeoVax Labs, Inc.
GOVX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,955 | $0 | $82 | $386 |
| % Growth | – | -100% | -78.9% | – |
| Cost of Goods Sold | $95 | $20,721 | $9,123 | $0 |
| Gross Profit | $3,859 | -$20,721 | -$9,042 | $386 |
| % Margin | 97.6% | – | -11,090.9% | 100% |
| R&D Expenses | $23,714 | $20,721 | $9,123 | $15,554 |
| G&A Expenses | $5,385 | $6,022 | $4,987 | $3,577 |
| SG&A Expenses | $5,385 | $5,948 | $4,987 | $3,577 |
| Sales & Mktg Exp. | $0 | -$74 | $0 | $0 |
| Other Operating Expenses | -$95 | -$20,647 | -$9,123 | $0 |
| Operating Expenses | $29,003 | $6,022 | $4,987 | $19,131 |
| Operating Income | -$25,144 | -$26,743 | -$14,029 | -$18,746 |
| % Margin | -635.8% | – | -17,207.5% | -4,862.7% |
| Other Income/Exp. Net | $152 | $776 | $7 | $176 |
| Pre-Tax Income | -$24,992 | -$25,967 | -$14,021 | -$18,570 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$24,992 | -$25,967 | -$14,021 | -$18,570 |
| % Margin | -632% | – | -17,198.3% | -4,817.2% |
| EPS | -4.82 | -10.22 | -5.52 | -7.3 |
| % Growth | 52.8% | -85.1% | 24.4% | – |
| EPS Diluted | -4.82 | -10.22 | -5.52 | -7.3 |
| Weighted Avg Shares Out | 5,187 | 2,540 | 2,540 | 2,540 |
| Weighted Avg Shares Out Dil | 5,187 | 2,540 | 2,540 | 2,540 |
| Supplemental Information | – | – | – | – |
| Interest Income | $173 | $776 | $7 | $5 |
| Interest Expense | $21 | $0 | $0 | $1 |
| Depreciation & Amortization | $95 | $74 | $56 | $39 |
| EBITDA | -$24,876 | -$26,669 | -$13,972 | -$18,531 |
| % Margin | -629% | – | -17,138.4% | -4,806.9% |